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Results: Of 16,043 patients undergoingCEA in 2012–13, 276 received at least
one transfusion prior to discharge (1.7%). 42% of transfusions occurred on the
day of surgery. Patients receiving a transfusion had worse clinical 30-day out-
comes: stroke (6% vs. 1% for control group, P< 0.001); myocardial infarction
(8% vs. 1%, P< 0.001); mortality (6% vs. 0.6%, P< 0.001) (Fig.1). Preoper-
ative hematocrit < 30% (Odds ration OR: 57.4; 95% confidence interval CI:
29.6-111.1), dependent functional status (OR: 2.7; 95%CI: 1.5-5.1), coagulopa-
thy (OR: 2.5; 95%CI: 1.7-3.6) and creatinine ≥ 1.2 mg/dl (OR: 2.3; 95%CI:
1.6-3.3) among other risk factors predicted transfusion (Fig.2). A risk prediction
model based on these data produced a C-statistic of 0.861; application of this
model to the validation set demonstrated a C-statistic of 0.850. 97% of patients
in the validation set received a score of 4 or less corresponding to an individual
predicted transfusion risk of 5% (Fig.3). Omitting a T&S in these patients would
generate a potential annual cost saving for NSQIP hospitals of over $5,400,000
based on our institutional cost.
Conclusion: While T&S is commonly performed for patients undergoing
CEA, transfusion following CEA is rare and well predicted by a transfusion
risk score. Avoidance of T&S in this low-risk population provides a substantial
cost-saving opportunity without compromise of patient care.
Use of the STAT (Sutureless Telescoping Anastomosis Technique)
to facilitate supraaortic revascularization: Mid-term Results:
Z. Rancic1, F. Pecoraro1, G. Puippe2, T. Pfammatter2, L. Chaykovska1,
C. A. Schmidt1, D. Mayer1, F. J. Veith1,3, M. Lachat1
1Clinic for Cardiovascular Surgery & 2Institute for Diagnostic and Interventional
Radiology, University Hospital of Zurich, Zurich, Switzerland, 3Division of Vascular
Surgery, Department of Surgery, University of New York, New York, USA
Objective: We report the mid-term results of use of a sutureless telescoping
anastomosis technique (STAT), the modification of technique initially described
as VORTEC, for revascularization of supra-aortic vessels.
Methods: Between January 2009 and December 2004, 55 patients (37 males)
with an aortic arch lesion underwent trans-sternal debranching with sutureless
telescoping anastomosis. The underlying aortic pathologies were: isolated aortic
arch aneurysm (10 patients), aortic arch aneurysm extending to ascending or
descending aorta (26), subclavian artery aneurysm (3), traumatic aortic rupture
(1), aortic dissection (10), and other arch pathologies as aortic ulcer of floating
thrombus (5). Follow-up included computed tomography angiography at 1, 3,
and 6 months postoperatively, and then annually.
Results: Overall, 148 supra-aortic vessels in the 55 patients were revascular-
ized: 127 by STAT and 21 by sutured surgical anastomosis. Immediate technical
success was 100%. There was no early graft occlusion and late graft occlusion
was detected in two patients. Perioperative mortality was 7.3% (one postoper-
ative bleeding, one retrograde dissection, one MOF (multi-organ failure) and
one cerebral bleeding). Mean follow-up (FU) at June 2015 was 45.12 months:
45 patients with FUmore than 2 years, 36 more than 3years and 23 more than 4
years. Patients’ cumulative survival at 4 years was 84%.There were no difference
in patency rate between STAT and sutured anastomosis.
Conclusion: Sutureless telescoping anastomosis technique (STAT) reduces
technical difficulties and invasiveness of aortic surgery (reduces ischemia time,
no clamping or circumferential dissection). This technique allows performing
anastomosis where sutured anastomosis is challenging (dissection, intramural
hematoma). Mid-term results confirm that sutureless anastomosis is safe and
reliable alternative to sutured one.
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Objective: Endovascular therapy for aortic and peripheral interventions is
increasingly becoming the first line treatment modality for a wide array of
disease processes. High definition fluoroscopic imaging is required to perform
these procedures, which are furthermore growing in complexity resulting in high
radiation exposure to patient and providers. This is of particular importance
for training institutions as residents and fellows despite instruction in ALARA
principles tend to have high radiation exposures. Recently, there was an upgrade
of the fixed imaging system at our institution. We used this opportunity to
compare radiation exposure to patients and providers before and after the
upgrade.
Methods: We performed a retrospective analysis of consecutive EVAR and
SFA interventions at our institution in the years 2013–14 and created two
cohorts: pre and post upgrade. We analyzed BMI, fluoroscopy times (FT) and
air kerma (AK), and thenmatched 1:1 based on fluoroscopy times as well as BMI.
We also analyzed individual surgeons’ badge readings. The fixed imaging system
was Allura Xper FD20 and was upgraded to Allura Clarity FD20 (both Philips
Heathcare).
Results: We identified a total of 76 EVARs (53 pre, 23 post) and 123 SFA
interventions (99, 24) yielding cohorts of 23 patients each for EVAR analysis
and of 24 patients each for SFA analysis. Complete data are shown in table 1.
There was a 52% reduction in AK for EVAR and 72% for SFA interventions,
respectively (p< 0.001 for both). 5/6 surgeons experienced a reduction in their
average monthly badge readings after system upgrade (Figure 1), most notably
the fellow from 512 to 109 mrem (p= 0.0032).
Conclusion: Aortic and peripheral endovascular interventions can be per-
formed with reduced radiation exposure to patients and providers employing
modern fixed imaging systems. This is of particular importance in light of more
complex procedures such as fenestrated and branched endografting that will
require substantial fluoroscopy to perform.
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Objective: The early postoperative benefits after endovascular aneurysm
repair (EVAR) need to be balanced against late complications and
re-intervention rates. The role of type II endoleaks (EL) and their treatment
unclear. The aim of this study is to report the treatment effect of preemptive
embolization of the inferior mesenteric artery (IMA) prior to EVAR.
Methods: We analysed all patients treated with elective EVAR between Jan-
uary 2001 and December 2012. Size and patency of the IMA were assessed from
the latest preoperativeCT-angiography. Preemptive embolization had been per-
formed if the IMA-diameter was ≥3mm. To maximize comparability between
patients’ measurements, we linearly interpolated diameters in time to obtain
two-year endpoints for patients not having CT-scans at 24± 1 month. Study
endpoints included aneurysm diameter change after 24 months, type II EL
and re-interventions as well as overall survival. Follow-up controls were per-
formed with CT angiography at 1 month, 6 months, 12 months and annually
thereafter.
Results: During this period 251 patients underwent EVAR for abdominal aor-
tic aneurysm. 42 patients with preoperatively occluded IMA were excluded. Of
those with patent IMA, 46/209 (22%) underwent preemptive IMA embolization.
Mean follow-up time was 6.2 years (range 1.5-13.4 years). At baseline as well
after 24 months, there was no significant difference regarding aneurysm diam-
eter between the embolized and the non-embolized group, (56.9± 8.9mm vs.
56.6± 9.8mm, p= 0.88 and 52.6± 17.2mm vs. 50.8± 17.7mm, p= 0.55 respec-
tively). Type II EL due to patent IMA was higher in the non-embolized 36/163
(22%) vs. 1/46 (2%) in the embolized group (p≤0.001). Three (1.8%) late
embolizations of the IMA were needed because of aneurysm sac progression in
the non-embolized group and no re-intervention was needed in the embolized
group. No difference in mortality rate was detected at any time between both
groups (0.6% vs 0.0%, p= 0.594 after 30-days; 5.5% vs. 4.3%, p= 0.753 after 1
year; 16.8% vs. 11.6%, p= 0.425 after 3 years and 38.3% vs. 23.3%, p= 0.116
after 5 years follow-up, respectively).
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